Publications in collaboration with researchers from Universidad Francisco de Vitoria (2)

2025

  1. Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson's disease

    Brain, Behavior, and Immunity, Vol. 128, pp. 600-611

2018

  1. Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system

    Biochemical Pharmacology, Vol. 157, pp. 67-84